What is PT Medikaloka Hermina Tbk Cash Flow from Financing?
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
three
months ended in Mar. 2024,
PT Medikaloka Hermina Tbk receivedRp106,388 Mil more from issuing new shares than it paid to buy back shares.
It spentRp39,552 Mil paying down its debt.
It paidRp0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It receivedRp0 Mil from paying cash dividends to shareholders.
It spentRp7,928 Mil on other financial activities.
In all, PT Medikaloka Hermina TbkearnedRp58,908 Mil on financial activities for the
three
months ended in Mar. 2024.
PT Medikaloka Hermina Tbk Cash Flow from Financing Historical Data
The historical data trend for PT Medikaloka Hermina Tbk's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
PT Medikaloka Hermina Tbk Cash Flow from Financing Chart
PT Medikaloka Hermina Tbk Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
PT Medikaloka Hermina Tbk's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp435,693 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Medikaloka Hermina Tbk (ISX:HEAL) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
PT Medikaloka Hermina Tbk's issuance of stock for the
three
months ended in Mar. 2024 was Rp106,388 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
PT Medikaloka Hermina Tbk's repurchase of stock for the
three
months ended in Mar. 2024 was Rp0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
PT Medikaloka Hermina Tbk's net issuance of debt for the
three
months ended in Mar. 2024 was Rp-39,552 Mil.
PT Medikaloka Hermina Tbk spentRp39,552 Mil paying down its debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
PT Medikaloka Hermina Tbk's net issuance of preferred for the
three
months ended in Mar. 2024 was Rp0 Mil.
PT Medikaloka Hermina Tbk paidRp0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
PT Medikaloka Hermina Tbk's cash flow for dividends for the
three
months ended in Mar. 2024 was Rp0 Mil.
PT Medikaloka Hermina Tbk receivedRp0 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
PT Medikaloka Hermina Tbk's other financing for the
three
months ended in Mar. 2024 was Rp-7,928 Mil.
PT Medikaloka Hermina Tbk spentRp7,928 Mil on other financial activities.
PT Medikaloka Hermina Tbk Cash Flow from Financing Related Terms
Thank you for viewing the detailed overview of PT Medikaloka Hermina Tbk's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.
PT Medikaloka Hermina Tbk (ISX:HEAL) Business Description
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ISX:HEAL has been successfully added to your 